Insider selling
Traded May 8 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade +50.3% · S&P 500 −6.5% · to Nov 20
A Bio-Techne director sold $320K of Bio-Techne shares. The filing does not indicate a pre-arranged trading plan.
